Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
Clinical trial NCT04680468 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04680468
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2026-11-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.